ARTICLE | Company News
Cellect, Hadassah deal
December 2, 2016 9:07 PM UTC
Hadassah's Hadasit Ltd. technology transfer arm partnered with Cellect to conduct preclinical studies of Cellect’s ApoGraft to treat graft-versus-host disease (GvHD). Hadassah will conduct the studies...